封面
市場調查報告書
商品編碼
2058295

天然生物材料市場:按產品類型、應用和地區分類

Natural Biomaterials Market, By Product Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 136 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年天然生物材料市場規模估計為867億美元,預計2033年將達到1,033億美元。預計2026年至2033年,該市場將以4.8%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 867億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 4.80% 2033年市場規模預測: 1033億美元

生物材料是指用於增強、取代或治療生物體組織、器官或功能的非藥物材料。生物材料的定義已被重新定義為:適合植入生物體以取代或增強生物組織和器官功能的非藥物物質。這些材料可以是合成的或天然的,可以是非生物的或生物來源的,並且由多種與生物系統相互作用的成分組成。它們可以用作生物體活組織的替代品。

市場動態

精準醫療和分子生物學領域研發投入的增加是市場擴張的主要驅動力。老年人口的成長,以及由此帶來的各種慢性疾病風險,也是推動天然生物材料需求成長的因素之一。生物材料科學在包括藥物傳輸裝置、整形外科、組織工程和其他醫療植入在內的各種先進醫療技術中的應用日益廣泛,預計在不久的將來進一步推動市場成長。

生物材料廣泛應用於藥物輸送,並且由於其可生物分解的特性,在完成其功能後會從體內消失。它們可用於多種醫療應用,例如骨替代、整形外科手術中的軟骨再生、膠原蛋白膜以及再生牙科。組織工程技術的進步以及膝關節和髖關節置換術數量的增加,為全球天然生物材料市場的發展創造了巨大的機會。領先企業在開發先進生物材料產品方面所進行的大量研發活動,預計也將進一步推動市場成長。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球天然生物材料市場的主要參與者進行了分析:公司概況、財務績效、產品系列、企業發展區域、分銷策略、主要發展和策略以及未來計劃。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球天然生醫材料市場報告旨在為行業內的各種相關人員提供參考,包括投資者、供應商、天然生醫材料製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球天然生醫材料市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • PEST分析
    • 波特五力分析
    • 市場機遇
    • 監管趨勢
    • 主要進展
    • 產業趨勢

第4章 全球天然生物材料市場:依產品類型分類,2021-2033年

  • 玻尿酸
  • 膠原蛋白
  • 明膠
  • 纖維蛋白
  • 纖維素
  • 幾丁質/幾丁聚醣
  • 其他

第5章 全球天然生物材料市場:依應用領域分類,2021-2033年

  • 心血管系統
  • 整形外科
  • 牙科
  • 整形外科
  • 創傷治療
  • 神經病學
  • 神經系統疾病/中樞神經系統
  • 組織工程
  • 眼科
  • 其他

第6章 全球天然生物材料市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東和非洲
  • 中東
  • 非洲

第7章 競爭情勢

  • 熱圖分析
  • 市佔率分析(3x3矩陣)
  • 公司簡介
    • BASF SE
    • Biomet, Inc.
    • Invibio Ltd.
    • Botiss Biomaterials GmbH
    • Medtronic, Inc.
    • Mimetis Biomaterials
    • Royal DSM
    • Corbion NV

第8章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2535

Natural Biomaterials Market is estimated to be valued at USD 86.7 Bn in 2026 and is expected to reach USD 103.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 86.7 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 4.80% 2033 Value Projection: USD 103.3 Bn

Biomaterials are regarded as non-drug material, which is used for enhancing or replacing and treating any tissue, organ or function in an organism. The definition of biomaterial was reframed as a non-drug substance, which is suitable for inclusions in systems, replacing or augmenting the function of body tissue or organ. This materials can be synthetic or natural, non-living or living, and are made of multiple components that interact with biological system. They are compatible to be used in place of living tissues in organisms.

Market Dynamics

Increase in investment in research and development of precision medicine and molecular biology is the key factor augmenting the market. Rise in geriatric population that is prone to various chronic diseases is another factor boosting the demand for natural biomaterials. Growth in usage of biomaterial science in various advanced medical technologies, such as drug delivery devices, plastic surgery, tissue engineering, and other medical implants, is expected to propel the market growth in the near future.

Biomaterials are widely used in drug delivery and are biodegradable so that they can disappear from organism after the completion of their function. These can be used in medical applications as replacement to bones, cartilage regeneration during an orthopedic surgery, collagen membrane and regenerative dentistry. Advancements in tissue designing and increase in number of knee and hip replacement surgeries have created lucrative opportunities for the global natural biomaterials market growth. Extensive research and development activities supported by key players to develop advanced biomaterial products is also anticipated to boost the market growth.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global natural biomaterials market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include, BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future products launches, technology up gradation, market expansion, and marketing tactics
  • The global natural biomaterials market report caters to various stakeholders in this industry including investors, suppliers, natural biomaterials manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global natural biomaterials market

Market Segmentation

  • By Product Type (Revenue, USD Bn, 2021-2033)
    • Hyaluronic Acid
    • Collagen
    • Gelatin
    • Fibrin
    • Cellulose
    • Chitin/chitosan
    • Others
  • By Application (Revenue, USD Bn, 2021-2033)
    • Cardiovascular
    • Orthopedic
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Neurology
    • Neurological Disorders/Central Nervous Systems
    • Tissue Engineering
    • Ophthalmology
    • Others
  • By Region (Revenue, USD Bn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • BASF SE
    • Biomet, Inc.
    • Invibio Ltd.
    • Mimetis Biomaterials
    • Royal DSM
    • Corbion N.V.
    • Botiss Biomaterials GmbH
    • Medtronic, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Natural Biomaterials Market, By Product Type, 2021-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hyaluronic Acid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Collagen
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Gelatin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Fibrin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cellulose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Chitin/Chitosan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Natural Biomaterials Market, By Application, 2021-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Neurological Disorders/Central Nervous Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Natural Biomaterials Market, By Region, 2021-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2033
  • North America
    • Market Share Analysis, By Country, 2021-2033
    • Y-o-Y Growth Analysis, By Country, 2021-2033
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033 (USD Bn)
    • Countries
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2021-2033
    • Y-o-Y Growth Analysis, By Country, 2021-2033
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033 (USD Bn)
    • Countries
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2021-2033
    • Y-o-Y Growth Analysis, By Country, 2021-2033
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033 (USD Bn)
    • Countries
      • France
      • Germany
      • Italy
      • Spain
      • U.K.
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2021-2033
    • Y-o-Y Growth Analysis, By Country, 2021-2033
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033 (USD Bn)
    • Countries
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East & Africa
    • Market Share Analysis, By Country, 2021-2033
    • Y-o-Y Growth Analysis, By Country, 2021-2033
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033 (USD Bn)
    • Countries
  • Middle East
  • Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • BASF SE
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates
    • Biomet, Inc.
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates
    • Invibio Ltd.
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates
    • Botiss Biomaterials GmbH
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates
    • Medtronic, Inc.
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates
    • Mimetis Biomaterials
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates
    • Royal DSM
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates
    • Corbion N.V.
      • Company Overview
      • Product Portfolio
      • Recent Developments/Updates

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact